To further investigate the regulatory effect of SETMAR on the differentiation of thyroid cancer, we overexpressed SETMAR in two ATC cell lines (CAL‐62 and BHT101) that had relatively low levels of endogenous SETMAR expression (Figure 3A). The gene discussed is SETMAR; the disease is thyroid gland carcinoma.